Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Sihuan Pharmaceutical Holdings Group ( (HK:0460) ).
Sihuan Pharmaceutical Holdings Group Ltd. has announced a change in the composition of its Nomination Committee, with Ms. Chen Yanling, an existing executive director, appointed as a new member effective from September 1, 2025. This change is expected to enhance the effectiveness and diversity of the Board, thereby improving the company’s overall corporate governance practices.
The most recent analyst rating on (HK:0460) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on Sihuan Pharmaceutical Holdings Group stock, see the HK:0460 Stock Forecast page.
More about Sihuan Pharmaceutical Holdings Group
Sihuan Pharmaceutical Holdings Group Ltd. is a company incorporated in Bermuda, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 114,359,493
Technical Sentiment Signal: Buy
Current Market Cap: HK$13.44B
For a thorough assessment of 0460 stock, go to TipRanks’ Stock Analysis page.